Molecular screening for somatic mutations in corticotropic adenomas of dogs with pituitary-dependent hyperadrenocorticism

Journal of Endocrinological Investigation

Volumn 20, Issue 1, 1997, Pages 1-7

  Van Wijk, P A ^a   Rijnberk, A ^a   Croughs, R J M ^b   Meij, B P ^a   Van Leeuwen, I S ^a   Sprang, E P M ^a   Mol, J A ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Corticotropic adenoma; Dog; Glucocorticoid receptor; Gs , H , K and N ras gene

Indexed keywords

COMPLEMENTARY DNA; CORTICOTROPIN; DNA BINDING PROTEIN; GLUCOCORTICOID RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL TISSUE; ARTICLE; CANCER GENETICS; CONTROLLED STUDY; GENETIC SCREENING; HYPERADRENOCORTICISM; HYPOPHYSIS ADENOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE N RAS; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; SOMATIC MUTATION;

EID: 0030935452     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347964     Document Type: Article

References (50)

1. Alexander J.M., Biller B.M.K., Bikkal H., Zervas N.T., Arnold A., Klibanski A. Clinically nonfunctioning pituitary tumors are monoclonal in origin. J. Clin. Invest. 86: 336, 1990.
2. Herman V., Fagin J., Gonsky R., Kovacs K., Melmed S. Clonal origin of pituitary adenomas. J. Clin. Endocrinol. Metab. 71: 1427, 1990.
3. Schulte H.M., Oldfield E.H., Allolio B., Katz D.A., Berkman R.A., Unnisa Ali I. Clonal composition of pituitary adenomas in patients with Cushing's disease: determination by X-chromosome inactivation analysis. J. Clin. Endocrinol. Metab. 73: 1302, 1991.
4. Gicquel C., Bouc le Y., Luton J.P., Girard F., Bertagna X. Monoclonality of corticotroph macroadenomas in Cushing's disease. J. Clin. Endocrinol. Metab. 75: 472, 1992.
5. Biller B.M.K., Alexander J.M., Zervas N.T., Hedley-While E.T., Arnold A., Klibanski A. Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease. J. Clin. Endocrinol. Metab. 75: 1303, 1992.
6. Melmed S., Braunstein G.D., Horvath E., Ezrin C., Kovacs K. Pathophysiology of acromegaly. Endocr. Rev. 4: 271, 1983.
7. Faglia G. Epidemiology and pathogenesis of pituitary adenomas. Acta Endocrinol. (Copenh.) 129(Suppl. 1): 1, 1993.
8. Vallar L., Spada A., Giannattasio G. Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature 330: 566, 1987.
9. Landis C.A., Masters S.B., Spada A., Pace A.M., Bourne H.R., Vallar L. GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340: 692, 1989.
10. Barbacid M.A. Ras genes. Ann. Rev. Biochem. 56: 779, 1987.
11. Dhanasekaran N., Heasley L.E., Johnson G.L. G protein-coupled receptor systems involved in cell growth and oncogenesis. Endocr. Rev. 16: 259, 1995.
12. Spada A., Vallar L. Faglia G. G-protein oncogenes in endocrine disorders. Progress in NeuroEndocrinImmunology 5: 80, 1992.
13. Karga H.J., Alexander J.M., Hedley-White E.T., Klibanski A., Jameson J.L. Ras mutations in human pituitary tumors. J. Clin. Endocrinol. Metab. 74: 914, 1992.
14. Pei L., Melmed S., Scheithauer B., Kovacs K., Prager D. H-ras mutations in human pituitary carcinoma metastases. J. Clin. Endocrinol. Metab. 78: 842, 1994.
15. Tomori N., Suda T., Tozawa F., Demura H., Shimuze K., Mouri T. Immunoreactive corticotropin-releasing factor concentrations in cerebrospinal fluid from patients with hypothalamic-pituitary-adrenal disorders. J. Clin. Endocrinol. Metab. 57: 1305, 1983.
16. Kling M.A., Roy A., Doran A.R., Calabrese J.R., Rubinow D.R., Whitfield H.J., May Jr. C., Post R.M., Chrousos G.P., Gold P.W. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications. J. Clin. Endorinol. Metab. 72: 260, 1991.
17. Van Wijk P.A., Rijnberk A., Croughs R.J.M., Voorhout G., Sprang E.P.M., Mol J.A. Corticotropin-releasing hormone and adrenocorticotropic hormone concentrations in cerebrospinal fluid of dogs with pituitary-dependent hyperadrenocorticism. Endocrinology 131: 2659, 1992.
18. Van Wijk P.A., Rijnberk A., Croughs R.J.M., Wolfswinkel J., Selman P.J., Mol J.A. Responsiveness to corticotropin-releasing hormone and vasopressin in canine Cushing's syndrome. Eur. J. Endocrinol. 130: 410, 1994.
19. Mol J.A., Slob A. Middleton D.J., Rijnberk A. Release of adrenocorticotropin, melanotropin and β-endorphin by pituitary tumors of dogs with pituitary-dependent hyperadrenocorticism. Front. Horm. Res. 17: 61, 1987.
20. Johnson G.L., Dhanasakaran N. The G-protein family and their interaction with receptors. Endocr. Rev. 10: 317, 1989.
21. Williamson E.A., Harrison D., Ince P.G., Kendall-Taylor P., Harris P.E. G-protein mutations in human pituitary adrenocorticotrophic hormone-secreting adenomas. Eur. J. Clin. Invest. 25: 128, 1995.
22. Hurley D.M., Accili D., Stratakis C.A. Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J. Clin. Invest. 87: 680, 1991.
23. Lamberts S.J.W., Koper J.W., Biemond P., den Holder F.H., de Jong F.H. Cortisol receptor resistance. The variability of its clinical presentation and response to treatment. J. Clin. Endocrinol. Metab. 74: 313, 1992.
24. Malchoff D.M., Brufsky A., Reardon G., McDermott P., Javier E.C., Bergh C.H., Rowe D., Malchoff C.D. A mutation of the glucocorticoid receptor in primary cortisol resistance. J. Clin. Invest. 91: 1918, 1993.
25. Nawata H., Sediya K., Higuchi K., Kato K.I., Ibayashi H. Decreased deoxyribonucleic acid binding of glucocorticoid-receptor complex in cultured skin fibroblasts from a patient with the glucocorticoid resistance syndrome. J. Clin. Endocrinol. Metab. 65: 219, 1984.
26. Rijnberk A., Mol J.A. Adrenocortical function. In: Kaneko J.J. (Ed.), Clinical biochemistry of domestic animals. Academic Press, San Diego, 1989, p. 611.
27. Voorhout G., Rijnberk A. Cisternography combined with linear tomography for visualization of pituitary lesions in dogs with pituitary-dependent hyperadrenocorticism. Vet. Radiol. 31: 74, 1990.
28. Markowitz J., Archibald J., Downie H.G. Hypophysectomy in dogs. In: Experimental Surgery. The Williams & Wilkins Co., Baltimore, 1964, p. 630.
29. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocynate-phenol-chloroform extraction. Anal. Biochem. 162: 156, 1987.
30. Madewell B.R., Gumerlock P.M., Saunders K.A., Meyers F.J., Kraegel S.A., Kawasaki E.S. Canine and bovine Ras family expression detected and discriminated by use of polymerase chain reaction. Anticancer Res. 9: 1743, 1989.
31. Hollenberg S.M., Weinberger C., Ong E.S., Cerelli G., Oro A., Lebo R., Thompson E.B., Rosenfeld M.G., Evans R.M. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318: 635, 1985.
32. Orita M., Iwahana H., Kanaza H., Hayashi K., Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl. Acad. Sci. USA 86: 2766, 1989.
33. Davis L.G., Dibner M.D., Battey J.F. Silver staining of gels for proteins or RNA. In: Basic methods in molecular biology. Elsevier Science Publishing Co., Inc., New York, 1986, p. 315.
34. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning-a laboratory manual, ed. 2. Cold Spring Harbor Laboratory, Cold Spring Harbor, 1989.
35. Kozasa T., Itoh H., Tsukamoto T., Kaziro Y. Isolation and characterization ofthe human Gsα gene. Proc. Natl. Acad. Sci. USA 85: 2081, 1988.
36. Saunders K.A., Madewell B.R., Oreffo V.I.C., Kraegel S.A., Gumerlock P.H. Nucleotide sequence of canine c-N-ras: codon 1 to 71. Am. J. Vet. Res. 53: 600, 1992.
37. Kraegel S.A., Gumerlock P.H., Dungworth D.L., Oreffo V.I., Madewell B.R. K-ras activation in non-small cell lung cancer in the dog. Cancer Res. 52: 4724, 1992.
38. Miesfeld R., Rusconi S., Godowski P.J., Maler B.A., Okret S., Wikstrom A., Gustafsson J., Yamamoto K.R. Genetic complementation of a glucocorticoid receptor deficiency by expression of cloned receptor cDNA. Cell 146: 389, 1986.
39. Klibanski A. Editorial: further evidence for a somatic mutation theory in the pathogenesis of human pituitary tumors. J. Clin. Endocrinol. Metab. 71: 1415A, 1990.
40. Tordjman K., Naftali S., Ouaknine G., Yossipov Y., Razon N., Nordenskjöld M., Friedman E. Activating mutations of the Gsα-gene in nonfunctioning pituitary tumors. J. Clin. Endocrinol. Metab. 77: 765, 1993.
41. Cai W.Y., Alexander J.M., Hedley-White E.T., Scheithauer B.W., Jameson J.L., Zervas N.T., Klibanski A. Ras mutations in human prolactinomas and pituitary carcinomas. J. Clin. Endocrinol. Metab. 78: 89, 1994.
42. Herman V., Drazin N.Z., Gonsky R., Melmed S. Molecular screening of pituitary adenomas for gene mutations and rearrangements. J. Clin. Endocrinol. Metab. 77: 50, 1993.
43. Yoshimoto K., Iwahana H., Fukuda A., Sano T., Katsuragi K., Kinoshita M., Saito S., Itakura M. Ras mutations in endocrine tumors: mutation detection by polymerase chain reaction-single strand conformation polymorphism. Jpn. J. Cancer Res. 83: 1057, 1992.
44. Prosser J. Detecting single-base mutations. Tib Tech. 11: 238, 1993.
45. Alvaro V., Levy L., Dubray C., Roche A., Peillon F., Querat B, Joubert D. Invasive human pituitary tumors express a point-mutated α-protein kinase-c. J. Clin. Endocrinol, Metab. 77: 1125, 1993.
46. Byström C., Larsson C., Blomberg C., Sandelin K., Falkmer U., Skogseid B., Oberg K., Werner S., Nordenskjold M. Localization of the MEN1 gene to a small region within chromosome 11 q13 by deletion mapping in tumors. Proc. Natl. Acad. Sci. USA 87: 1968, 1990.
47. Boggild M.D., Jenkinson S., Pistorello M., Boscaro M., Scanarini M., McTernan P., Perret C.W., Thakker R.V., Clayton R.N. Molecular genetic studies of sporadic pituitary tumors. J. Clin. Endocrinol. Metab. 78: 387, 1994.
48. Raghavan R., Harrison D., Ince P.G., James R.A., Daniels M., Birch P., Caldwell G.I., Kendall-Taylor P. Oncoprotein immunoreactivity in human pituitary tumours. Clin. Endocrinol. (Oxf.) 40: 117, 1994.
49. Buckley N., Bates A.S., Broome J.C., Strange R.C., Perret C.W., Burke C.W., Clayton R.N. P53 protein accumulates in Cushing's adenomas and invasive non-functional adenomas. J. Clin. Endocrinol. Metab. 80: erratum, 1995.
50. Harris P.E. Clinical and genetic changes in a case of a Cushing's carcinoma. Clin. Endocrinol. (Oxf.) 42: 671, 1995.